Patents by Inventor Anthony Handlon

Anthony Handlon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MrgX2 antagonists
    Patent number: 11976057
    Abstract: This invention relates to novel compounds according to Formula (I) which are antagonists of MrgX2, to pharmaceutical compositions containing them, and to their use in therapy for the treatment of MrgX2-mediated diseases and disorders.
    Type: Grant
    Filed: October 4, 2021
    Date of Patent: May 7, 2024
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Edward Brnardic, Michael Bury, Rodolfo Cadilla, Jon Collins, Yu Guo, Anthony Handlon, Huijie Li, Yue Li, Daniel Paone, Christie Schulte, Barry Shearer, Maben Ying, Guosen Ye, Huichang Zhang, Millard Hurst Lambert, III
  • MRGX2 ANTAGONISTS
    Publication number: 20220112174
    Abstract: This invention relates to novel compounds according to Formula (I) which are antagonists of MrgX2, to pharmaceutical compositions containing them, and to their use in therapy for the treatment of MrgX2-mediated diseases and disorders.
    Type: Application
    Filed: October 4, 2021
    Publication date: April 14, 2022
    Inventors: Edward BRNARDIC, Michael BURY, Rodolfo CADILLA, Jon COLLINS, Yu GUO, Anthony HANDLON, Huijie LI, Yue LI, Daniel PAONE, Christie SCHULTE, Barry SHEARER, Guosen YE, Maben YING, Huichang ZHANG
  • Arylamine mch r1 antagonists
    Publication number: 20070078125
    Abstract: This invention relates to novel arylamines which are antagonists of the melanin-concentrating hormone receptor 1 (MCH R1), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines for the treatment of obesity, diabetes, depression, and/or anxiety.
    Type: Application
    Filed: October 21, 2004
    Publication date: April 5, 2007
    Inventors: Kevin Barvian, Anthony Handlon, Donald Hertzog, Clifton Hyman
  • Heterocyclic mchr1 antagoists
    Publication number: 20060194871
    Abstract: This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11 CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines.
    Type: Application
    Filed: April 6, 2004
    Publication date: August 31, 2006
    Inventors: Kevin Barvian, Andrew Carpenter, Joel Cooper, Paul Feldman, Dulce Garrido, Yu Guo, Anthony Handlon, Donald Hertzog, Clifton Hyman, Andrew Peat, Gregory Peckham, Jason Speake, William Swain, Francis Tavares, Huiqiang Zhou
  • Condensed heterocyclic compounds as calcitonin agonists
    Publication number: 20050107419
    Abstract: The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions.
    Type: Application
    Filed: February 24, 2003
    Publication date: May 19, 2005
    Inventors: Ashok Bhandari, Eric Boros, David Cowan, Anthony Handlon, Clifton Hyman, Jeffrey Oplinger, Michael Rabinowitz, Philip Turnbull